UNSPSC 85571021: Revision of autologous tissue substitute in tracheobronchial tree, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in tracheobronchial tree, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0BW087Z

UNSPSC 85571021 Revision of autologous tissue substitute in tracheobronchial tree, via natural or artificial opening endoscopic is a Commodity code whose recent state and local activity shows no alignment with the nominal medical procedure scope. The six recent opportunities in the dataset — independent medical evaluations for disability retirement benefits, surgical benefit carve-out programs for municipal employees, occupational medical surveillance for state ferry workers, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing — all address administrative healthcare contracting, claims processing, occupational health screening, or staffing rather than tracheobronchial tissue revision procedures. None of the solicitations describe endoscopic procedures, autologous tissue grafting, or the clinical interventions the code nominally covers. The issuing bodies span state departments, county health systems, municipal retirement offices, and county juvenile probation departments across Arizona, California, Florida, and Washington.

The mismatch between the code's clinical focus and the actual procurement activity suggests either miscoding at the source or that this UNSPSC category does not reflect state and local contracting patterns for this procedure type. State and local procurement offices tag healthcare-related opportunities broadly and do not consistently map administrative health benefit services, occupational screening programs, or staffing arrangements to procedure-specific clinical codes. Unless the source material has miscoded these opportunities or the code is used differently than its name suggests, this category shows little relevant recent activity for firms pursuing autologous tissue or endoscopic procedure work. Business development professionals should verify whether the code reflects actual state and local spending on tracheobronchial interventions before investing pursuit resources.